Evotec SE (EVO) Interest & Investment Income (2009 - 2023)
Evotec SE's (EVO) quarterly Interest & Investment Income came in at $3.1 million in Q2 2023, up 136.24% year-over-year from $1.3 million in Q2 2022, and up 18.95% quarter-over-quarter from $2.6 million in Q4 2022.
Analysis
Evotec SE (EVO) Interest & Investment Income (2009 - 2023) Analysis & Trends
Evotec SE has disclosed Interest & Investment Income across 7 years of filings, most recently posting $3.1 million for Q2 2023.
- In Q2 2023, Interest & Investment Income rose 136.24% year-over-year to $3.1 million; the TTM figure through Jun 2023 stood at $10.8 million (up 197.95% YoY), while the FY2022 annual figure was $8.8 million, up 226.77% from the prior year.
- Interest & Investment Income came in at $3.1 million for Q2 2023 at Evotec SE, up from $2.6 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $3.8 million in Q3 2022 to a low of -$1.1 million in Q3 2020.
- Average Interest & Investment Income over 5 years is $1.3 million, with a median of $818365.2 recorded in 2022.
- Year-over-year, Interest & Investment Income sank 87.79% in 2020 and jumped 404.13% in 2022.
- Over 5 years, Interest & Investment Income stood at $2.3 million in 2019, then slumped by 87.79% to $277803.5 in 2020, then jumped by 144.6% to $679518.7 in 2021, then soared by 284.22% to $2.6 million in 2022, then gained by 18.95% to $3.1 million in 2023.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $3.1 million in Q2 2023, $2.6 million in Q4 2022, and $3.8 million in Q3 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | 7.00 Mn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 4.99 Mn |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | 1.03 Mn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | 3.16 Mn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | -19.30 Mn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | -210,000.00 |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | - |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | - |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | 28,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 3.11 Mn |
| Dec 31, 2022 | 2.61 Mn |
| Sep 30, 2022 | 3.79 Mn |
| Jun 30, 2022 | 1.31 Mn |
| Mar 31, 2022 | 885,524.46 |
| Dec 31, 2021 | 679,518.74 |
| Sep 30, 2021 | 751,206.02 |
| Jun 30, 2021 | 649,102.30 |
| Mar 31, 2021 | 605,530.53 |
| Dec 31, 2020 | 277,803.53 |
| Sep 30, 2020 | -1.06 Mn |
| Dec 31, 2019 | 2.28 Mn |
| Sep 30, 2010 | 34,864.36 |
| Jun 30, 2010 | 82,864.44 |
| Mar 31, 2010 | 116,315.62 |
| Dec 31, 2009 | 94,510.99 |
| Jun 30, 2009 | 156,589.56 |
| Mar 31, 2009 | 323,010.19 |